Disease burden associated with late-onset clinically significant cytomegalovirus infection among allogeneic haematopoietic stem cell transplant recipients initiating primary letermovir prophylaxis: a US claims analysis (ESCMID Global 2026) - Feb 4, 2026 - Pres time: Apr 19, 2026; 12:00 PM - 01:30 PM; Location: Poster area; No abstract available
Clinical • Cytomegalovirus Infection • Infectious Disease • Transplantation
|